DUTA-EV®
Sterile professional scalp solution pairing dutasteride 0.01% with Galactomyces-derived extracellular vesicles at 40 billion particles/mL: a dual-pathway approach to androgenetic hair loss.
MesoAge® DUTA-EV brings two complementary pathways into one formulation. Dutasteride 0.01% w/v (0.1 mg/mL) inhibits both Type I and Type II 5-alpha-reductase, modulating the androgen pathway that drives follicular miniaturization. Galactomyces-derived extracellular vesicles, standardized at 4.0 × 10¹⁰ particles/mL, support cellular communication in the follicular microenvironment.
DUTA-EV is designed to complement guideline-based hair management, not replace it. It fits alongside topical minoxidil, oral 5-alpha-reductase inhibitors, PRP, microneedling, and surgical restoration programs. Diagnosis and staging should precede any program.
Product-specific controlled studies are in development. MesoAge recommends documenting each case with standardized photography and trichoscopy at baseline, 3, 6, and 12 months.
- Mechanism
- Dual Type I + II 5-alpha-reductase inhibition with extracellular vesicle signaling support
- Concentration
- Dutasteride 0.01% w/v (0.1 mg/mL) · EVs 4.0 × 10¹⁰ particles/mL
- Pack size
- 5 × 10 mL vials
Active ingredients
- Dutasteride 0.01% w/v (0.1 mg/mL)
- Galactomyces-derived extracellular vesicles 4.0 × 10¹⁰ particles/mL
- Vitamin B complex 0.001%
- Copper tripeptide-1 (GHK-Cu) 0.0001%
- Fibroblast growth factor (FGF-2) 0.0001%
Application sites
- Scalp
Application method
- Sterile scalp solution for topical use
- For external use only. Do not inject.
- Each 10 mL vial delivers approximately 1 mg dutasteride and 4 × 10¹¹ EV particles
- Document outcomes with standardized photography and trichoscopy at baseline, 3, 6, and 12 months
Interested in DUTA-EV?
Contact our team for pricing, availability, and practitioner onboarding.
